Matrix metalloproteinasem1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours
1998

EGF Induces MMP1 in Bladder Tumor Cells and Urine

Sample size: 49 publication Evidence: moderate

Author Information

Author(s): JE Nutt, JK Mellon, K Qureshi, J Lunec

Primary Institution: University of Newcastle upon Tyne

Hypothesis

Does epidermal growth factor (EGF) induce matrix metalloproteinase-1 (MMP1) production in human bladder tumor cell lines?

Conclusion

MMP1 levels increase significantly in bladder tumor cell lines after EGF treatment and are detectable in the urine of patients with bladder tumors.

Supporting Evidence

  • EGF treatment led to a 20-fold increase in MMP1 mRNA levels in RT112 cells.
  • MMP1 protein was detected in urine from patients with bladder tumors.
  • Urine MMP1 concentrations increased with tumor stage and grade.

Takeaway

When bladder cancer cells are treated with a substance called EGF, they make more of a protein called MMP1, which can also be found in the urine of patients with bladder cancer.

Methodology

The study involved treating two human bladder tumor cell lines with EGF and measuring MMP1 mRNA and protein levels, as well as analyzing urine samples from patients.

Limitations

The study primarily focused on two cell lines and may not represent all bladder tumors.

Participant Demographics

Patients included 10 with stage T2-T4 tumors, 5 with stage T1, 17 with stage Ta tumors, and 17 clear of tumors.

Statistical Information

P-Value

0.029

Statistical Significance

p=0.003

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication